IMMUNOPRECISE ANTIBODIES LTD's ticker is and the CUSIP is 45257F950. A total of 3 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,840 | +754.9% | 4,000 | +700.0% | 0.00% | – |
| Q1 2023 | $1,385 | -82.6% | 500 | -66.7% | 0.00% | – |
| Q4 2022 | $7,950 | -73.5% | 1,500 | -79.7% | 0.00% | – |
| Q3 2022 | $30,000 | -11.8% | 7,400 | -14.9% | 0.00% | – |
| Q2 2022 | $34,000 | -12.8% | 8,700 | +14.5% | 0.00% | – |
| Q1 2022 | $39,000 | +1850.0% | 7,600 | +1800.0% | 0.00% | – |
| Q4 2021 | $2,000 | -77.8% | 400 | -73.3% | 0.00% | – |
| Q3 2021 | $9,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 500 | $1,385 | 0.00% |
| SIMPLEX TRADING, LLC | 9,400 | $26 | 0.00% |